Ferroptosis in chemotherapy resistance and resensitization in breast cancer: a systematic review of preclinical evidence and translational implications - Top-Institutions - MDSpire

Ferroptosis in chemotherapy resistance and resensitization in breast cancer: a systematic review of preclinical evidence and translational implications

  • By

  • Kezhen Shen

  • Heng Zhang

  • Lei Cai

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    State University of Campinas
    State University of Campinas

    Campinas, São Paulo

    Key Differentiators

    • Oncology

  • #4

    Federal Technological University of Paraná
    Federal Technological University of Paraná

    Londrina, Paraná

    Key Differentiators

    • Oncology

  • #5

    Cancer and Leukemia Group B
    Cancer and Leukemia Group B

    Chicago, Illinois

    Key Differentiators

    • Oncology

Original Source(s)

Ferroptosis in chemotherapy resistance and resensitization in breast cancer: a systematic review of preclinical evidence and translational implications

  • by Kezhen Shen, Heng Zhang, Lei Cai

  • July 1, 2026

Related Content

Molecular changes during AT/RT progression associated with epithelial–mesenchymal transition and extracellular matrix changes

Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer

Alectinib combined with 5-aminolevulinic acid-based photodynamic therapy promotes apoptosis in endometrial cancer cells by targeting ferrochelatase